Literature DB >> 17119062

Mammographic breast density, dense area, and breast area differences by phase in the menstrual cycle.

Diana S M Buist1, Erin J Aiello, Diana L Miglioretti, Emily White.   

Abstract

BACKGROUND: Mammographic breast density may be greater in the luteal phase (days 15-30) than the follicular phase (days 1-14) of the menstrual cycle; this may have implications for when mammography screening should occur.
OBJECTIVE: Examine whether percent breast density, breast area, or dense area differ by menstrual phase.
METHODS: We identified 204 premenopausal women with regular periods who were <55 years (mean = 45.0 years) and had two screening mammograms within 9 to 18 months, with one screening between days 9 and 14, and one screening between days 22 and 35 of the menstrual cycle. We measured percent breast density, breast area, and dense area using the Cumulus software. We used linear regression to test for differences in breast density, breast area, and dense area from follicular to luteal phase, adjusting for change in weight and time between exams.
RESULTS: The mean (SD) percent breast density was 35.8% (21.3) in the follicular phase and 36.7% (21.3) in the luteal phase. Multivariable analyses showed small but not statistically significant increases in percent density [1.1%; 95% confidence interval (95% CI), -0.2% to 2.3%] and breast area (16.7 cm(2); 95% CI, -2.8 to 36.2) and a statistically significant increase in dense area (13.1 cm(2); 95% CI, 0.1-26.1) in the luteal compared with the follicular phase.
CONCLUSIONS: Breast density, breast area, and dense area have small, but probably not clinically meaningful, increases in the luteal phase of the menstrual cycle. However, there are other factors that may differ by menstrual cycle phase that we were unable to assess (e.g., breast compression), which may ultimately influence mammographic sensitivity by menstrual cycle phase.

Entities:  

Mesh:

Year:  2006        PMID: 17119062     DOI: 10.1158/1055-9965.EPI-06-0475

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

1.  Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.

Authors:  Jennifer Eng-Wong; Jennifer Orzano-Birgani; Catherine K Chow; David Venzon; Jianhua Yao; Claudia E Galbo; Jo Anne Zujewski; Sheila Prindiville
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06-26       Impact factor: 4.254

2.  Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging.

Authors:  Siwa Chan; Min-Ying L Su; Fu-Ju Lei; Jia-Pei Wu; Muqing Lin; Orhan Nalcioglu; Stephen A Feig; Jeon-Hor Chen
Journal:  Radiology       Date:  2011-08-30       Impact factor: 11.105

3.  Accuracy of screening mammography varies by week of menstrual cycle.

Authors:  Diana L Miglioretti; Rod Walker; Donald L Weaver; Diana S M Buist; Stephen H Taplin; Patricia A Carney; Robert D Rosenberg; Mark B Dignan; Zhuo Tracy Zhang; Emily White
Journal:  Radiology       Date:  2010-12-03       Impact factor: 11.105

4.  Endogenous sex hormones and breast density in young women.

Authors:  Seungyoun Jung; Frank Z Stanczyk; Brian L Egleston; Linda G Snetselaar; Victor J Stevens; John A Shepherd; Linda Van Horn; Erin S LeBlanc; Kenneth Paris; Catherine Klifa; Joanne F Dorgan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-04       Impact factor: 4.254

5.  Effect of menstrual cycle phase on background parenchymal uptake at molecular breast imaging.

Authors:  Carrie B Hruska; Amy Lynn Conners; Celine M Vachon; Michael K O'Connor; Lynne T Shuster; Adam C Bartley; Deborah J Rhodes
Journal:  Acad Radiol       Date:  2015-06-22       Impact factor: 3.173

6.  Fertility drug use and mammographic breast density in a mammography screening cohort of premenopausal women.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Mary Beth Terry; Hazel B Nichols; Andrew J Bersch; Diana S M Buist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

Review 7.  Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Lee Hooper; Giri Madhavan; Jeffrey A Tice; Sam J Leinster; Aedín Cassidy
Journal:  Hum Reprod Update       Date:  2010-05-28       Impact factor: 15.610

8.  Short-term hormone therapy suspension and mammography recall: a randomized trial.

Authors:  Diana S M Buist; Melissa L Anderson; Susan D Reed; Erin J Aiello Bowles; E Dawn Fitzgibbons; Juleann C Gandara; Deborah Seger; Katherine M Newton
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

9.  Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle.

Authors:  J H Chen; W P Chen; S Chan; D C Yeh; M Y Su; C E McLaren
Journal:  Ann Oncol       Date:  2013-05-09       Impact factor: 32.976

10.  Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.

Authors:  Carolyn J Crandall; Mary E Sehl; Sybil L Crawford; Ellen B Gold; Laurel A Habel; Lesley M Butler; Maryfran R Sowers; Gail A Greendale; Janet S Sinsheimer
Journal:  Breast Cancer Res       Date:  2009-07-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.